Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01627210
- Locations
- 🇺🇸
Catalina Research Institute, Chino, California, United States
🇺🇸Desert Endocrinology Clinical Research Center, Henderson, Nevada, United States
🇺🇸Diabetes and Endocrine Associate, La Mesa, California, United States
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
- Conditions
- Diabetes Mellitus
- Interventions
- Device: Dexcom G4 CGM System
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT01627184
- Locations
- 🇺🇸
Atlanta Diabetes Association, Atlanta, Georgia, United States
Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4â„¢ Continuous Glucose Monitoring System
- Conditions
- Diabetes
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2012-01-23
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT01514305
- Locations
- 🇺🇸
Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, United States
Effectiveness and Safety Study of the Dexcom G4â„¢ Continuous Glucose Monitoring System
- Conditions
- Diabetes
- Interventions
- Device: Continuous Glucose Monitoring of glucose levels (Dexcom)
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2015-10-05
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT01514292
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
🇺🇸Diablo Clinical Research, Walnut Creek, California, United States
🇺🇸AMCR Institute, Inc., Escondido, California, United States
Effectiveness and Safety Study of the DexComâ„¢ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2011-06-13
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01185496
- Locations
- 🇺🇸
DexCom, Inc, San Diego, California, United States
Effectiveness and Safety Study of the DexComâ„¢ G4 Continuous Glucose Monitoring System
- Conditions
- Diabetes Mellitus
- Interventions
- Device: DexComâ„¢ G4 Continuous Glucose Monitoring System
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01111370
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: CGM
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2010-04-15
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT01104142
- Locations
- 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: Continuous Glucose Monitoring
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT00939289
- Locations
- 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting
- Conditions
- DiabetesHyperglycemia
- Interventions
- Device: IVBG
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT00925080
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
🇺🇸Advanced Metabolic Care + Research, Escondido, California, United States
🇺🇸Diabetes and Glandular Disease Research Associates, Inc., San Antonio, Texas, United States
Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System
- Conditions
- Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2008-07-25
- Lead Sponsor
- DexCom, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT00722241
- Locations
- 🇺🇸
John Muir Physician Network Clinical Research Center, Concord, California, United States
🇺🇸Advanced Metabolic Care + Research, Escondido, California, United States
🇺🇸Sansum Diabetes Research Institute, Santa Barbara, California, United States